Senores Pharma's ₹582 crore IPO opens today, closing December 24. The company aims to utilize proceeds for subsidiary investment, debt repayment, and working capital. Priced at ₹372-391 per share, the IPO has a ₹150 grey market premium. Analysts recommend subscribing, citing attractive valuations and high pharmaceutical demand.
